These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 25961450)

  • 41. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.
    Sharabi A; Mozes E
    Immunotherapy; 2009 May; 1(3):385-401. PubMed ID: 20635958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphocyte subsets in patients with systemic lupus erythematosus.
    DeHoratius RJ
    Arthritis Rheum; 1982 Jul; 25(7):828-32. PubMed ID: 7049186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SLE-Associated Defects Promote Altered T Cell Function.
    Crispin JC; Hedrich CM; Suárez-Fueyo A; Comte D; Tsokos GC
    Crit Rev Immunol; 2017; 37(1):39-58. PubMed ID: 29431078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TCR zeta-chain abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Warke VG; Tsokos GC
    Methods Mol Med; 2004; 102():49-72. PubMed ID: 15286380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defective B cell tolerance checkpoints in systemic lupus erythematosus.
    Yurasov S; Wardemann H; Hammersen J; Tsuiji M; Meffre E; Pascual V; Nussenzweig MC
    J Exp Med; 2005 Mar; 201(5):703-11. PubMed ID: 15738055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Target identification and validation in systemic autoimmunity.
    Peng SL
    Immunol Res; 2005; 32(1-3):201-9. PubMed ID: 16106071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Juang YT; Krishnan S; Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):245-63. PubMed ID: 15204087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus.
    Sim JH; Kim HR; Chang SH; Kim IJ; Lipsky PE; Lee J
    Arthritis Res Ther; 2015 Jul; 17(1):190. PubMed ID: 26209442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contributions of B cells to lupus pathogenesis.
    Sang A; Zheng YY; Morel L
    Mol Immunol; 2014 Dec; 62(2):329-38. PubMed ID: 24332482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic lupus erythematosus conundrums.
    Wardle EN
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):731-6. PubMed ID: 19736466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunopathogenesis of systemic lupus erythematosus: An update.
    Arnaud L; Chasset F; Martin T
    Autoimmun Rev; 2024 Oct; 23(10):103648. PubMed ID: 39343084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach.
    Tipton CM; Hom JR; Fucile CF; Rosenberg AF; Sanz I
    Immunol Rev; 2018 Jul; 284(1):120-131. PubMed ID: 29944759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The busy life of regulatory T cells in systemic lupus erythematosus.
    La Cava A
    Discov Med; 2009 Jun; 8(40):13-7. PubMed ID: 19772836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methods and protocols to study T cell signaling abnormalities in human systemic lupus erythematosus.
    Moulton VR; Lo MS; Tsokos GC
    Methods Mol Biol; 2012; 900():25-60. PubMed ID: 22933064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
    Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
    J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoimmunity, end organ damage, and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus.
    Lewis JE; Fu SM; Gaskin F
    Discov Med; 2013 Feb; 15(81):85-92. PubMed ID: 23449110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nature of IgG anti-lymphocyte autoantibody-reactive molecules shed from activated T cells in systemic lupus erythematosus.
    Minota S; Winfield JB
    Rheumatol Int; 1988; 8(4):165-70. PubMed ID: 3055216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.